Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis

Fitoterapia

Volumn 93, Issue , 2014, Pages 47-53

  Yang, Zi Feng ^a,c   Bai, Li Ping ^b   Huang, Wen Bo ^a   Li, Xu Zhao ^a   Zhao, Sui Shan ^a   Zhong, Nan Shan ^a,c   Jiang, Zhi Hong ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c National Clinical Research Center for Respiratory Disease   (China)

Author keywords

Antiviral; Influenza virus; Structure activity relationship; Tea polyphenols

Indexed keywords

ANTIVIRUS AGENT; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; KAEMPFEROL; MYRICETIN; POLYPHENOL DERIVATIVE; PROCYANIDIN; PROCYANIDIN B 2; PROCYANIDIN B 2 3,3' DI O GALLATE; PROCYANIDIN B 2 DIGALLATE; PROCYANIDIN DERIVATIVE; QUERCETIN; THEAFLAVIN; THEAFLAVIN 3,3' DIGALLATE; UNCLASSIFIED DRUG; POLYPHENOL; TEA;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MDCK CELL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STRUCTURE ACTIVITY RELATION; TEA; VIRUS INHIBITION; VIRUS STRAIN; ANIMAL; CAMELLIA SINENSIS; CHEMISTRY; COMPARATIVE STUDY; DOG; DRUG EFFECTS; MDCK CELL LINE; MICROBIAL SENSITIVITY TEST;

ANIMALS; ANTIVIRAL AGENTS; CAMELLIA SINENSIS; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MICROBIAL SENSITIVITY TESTS; POLYPHENOLS; STRUCTURE-ACTIVITY RELATIONSHIP; TEA;

EID: 84892722419     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.12.011     Document Type: Article

References (48)

1. M. Miller, C. Viboud, L. Simonsen, D.R. Olson, and C. Russell Mortality and morbidity burden associated with A/H1N1pdm influenza virus: who is likely to be infected, experience clinical symptoms, or die from the H1N1pdm 2009 pandemic virus ? PLoS Curr 1 2009 (RRN1013)
2. J.K. Taubenberger, A.H. Reid, T.A. Janczewski, and T.G. Fanning Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus Philos Trans R Soc Lond B Biol Sci 356 2001 1829 1839
3. V. Trifonov, H. Khiabanian, B. Greenbaum, and R. Rabadan The origin of the recent swine influenza A(H1N1) virus infecting humans Euro Surveill 14 2009 191 193
4. Authorizations, E.U Update: infections with a swine-origin influenza A (H1N1) virus - United States and other countries, April 28, 2009 Morbidity and Mortality Weekly Report. 58 2009
5. World Health Organization Number of confirmed human cases of avian influenza A(H7N9) reported to WHO http://www.who.int/entity/influenza/human- animal-interface/influenza-h7n9/09-ReportWebH7N9Number.pdf 2013
6. K. Tharakaraman, A. Jayaraman, R. Raman, K. Viswanathan, N.W. Stebbins, and D. Johnson et al. Glycan receptor binding of the influenza A virus H7N9 hemagglutinin Cell 153 2013 1486 1493
7. A.C. Hurt, T. Chotpitayasunondh, N.J. Cox, R. Daniels, A.M. Fry, and L.V. Gubareva et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives Lancet Infect Dis 12 2012 240 248
8. Y. Hu, S. Lu, Z. Song, W. Wang, P. Hao, and J. Li et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance Lancet 38 2013 2273 2279
9. M. Zu, F. Yang, W. Zhou, A. Liu, G. Du, and L. Zheng In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives Antiviral Res 94 2012 217 224
10. M. Zhu, J. David Phillipson, P.M. Greengrass, N.E. Bowery, and Y. Cai Plant polyphenols: biologically active compounds or non-selective binders to protein? Phytochemistry 44 1997 441 447
11. Q.V. Vuong, C.E. Stathopoulos, M.H. Nguyen, J.B. Golding, and P.D. Roach Isolation of green tea catechins and their utilization in the food industry Food Rev Int 27 2011 227 247
12. J.D. Lambert, and R.J. Elias The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention Arch Biochem Biophys 501 2010 65 72
13. C.S. Yang, and X. Wang Green tea and cancer prevention Nutr Cancer 62 2010 931 937
14. N. Khan, and H. Mukhtar Multitargeted therapy of cancer by green tea polyphenols Cancer Lett 269 2008 269 280
15. G.F. Ferrazzano, I. Amato, A. Ingenito, A. Zarrelli, G. Pinto, and A. Pollio Plant polyphenols and their anti-cariogenic properties: a review Molecules 16 2011 1486 1507
16. H.-C. Huang, and J.-K. Lin Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet Food Funct 3 2012 170 177
17. Y. Cao, and R. Cao Angiogenesis inhibited by drinking tea Nature 398 1999 381-381
18. D.E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, L. Masino, and R. Lurz et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat Struct Mol Biol 15 2008 558 566
19. H. Zhang, J.-R. Wang, L.F. Yau, H.M. Ho, C.L. Chan, and P. Hu et al. A cellular lipidomic study on the Aβ-induced neurotoxicity and neuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profiling and multivariate analysis Mol Biosyst 8 2012 3208 3215
20. S. Liu, H. Lu, Q. Zhao, Y. He, J. Niu, and A.K. Debnath et al. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 Biochim Biophys Acta (BBA)-Gen Subj 1723 2005 270 281
21. H. Yamada, N. Takuma, T. Daimon, and Y. Hara Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study J Altern Complement Med 12 2006 669 672
22. C.A. Rowe, M.P. Nantz, J.F. Bukowski, and S.S. Percival Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances γδ T cell function: a randomized, double-blind, placebo-controlled study J Am Coll Nutr 26 2007 445 452
23. K. Matsumoto, H. Yamada, N. Takuma, H. Niino, and Y. Sagesaka Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial BMC Complement Altern Med 11 2011 15
24. U.S. Food and Drug Administration http://www.accessdata.fda.gov/ drugsatfda-docs/nda/2006/021902s000TOC.cfm 2006
25. K. Ueda, R. Kawabata, T. Irie, Y. Nakai, Y. Tohya, and T. Sakaguchi Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a broad range of viruses PLoS ONE 8 2013 e55343
26. J.-M. Song, K.-H. Lee, and B.-L. Seong Antiviral effect of catechins in green tea on influenza virus Antiviral Res 68 2005 66 74
27. M. Nakayama, K. Suzuki, M. Toda, S. Okubo, Y. Hara, and T. Shimamura Inhibition of the infectivity of influenza virus by tea polyphenols Antiviral Res 21 1993 289 299
28. L.-P. Bai, H.-M. Ho, D.-L. Ma, H. Yang, W.-C. Fu, and Z.-H. Jiang Aminoglycosylation can enhance the G-quadruplex binding activity of epigallocatechin PLoS One 8 2013 e53962
29. C. Ehrhardt, E.R. Hrincius, V. Korte, I. Mazur, K. Droebner, and A. Poetter et al. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance Antiviral Res 76 2007 38 47
30. L.J. Reed, and H. Muench A simple method of estimating fifty percent endpoints Am J Epidemiol 27 1938 493 497
31. S. Yingsakmongkon, D. Miyamoto, N. Sriwilaijaroen, K. Fujita, K. Matsumoto, and W. Jampangern et al. In vitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC) Biol Pharm Bull 31 2008 511 515
32. B.S. Graham, M.D. Perkins, P.F. Wright, and D.T. Karzon Primary respiratory syncytial virus infection in mice J Med Virol 26 1988 153 162
33. M. Hui, E. Lien, and M. Trousdale Inhibition of human adenoviruses by 1-(2′-hydroxy-5′-methoxybenzylidene) amino-3-hydroxyguanidine tosylate Antiviral Res 24 1994 261 273
34. J. Johari, A. Kianmehr, M.R. Mustafa, S. Abubakar, and K. Zandi Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus Int J Mol Sci 13 2012 16785 16795
35. S. Ganesan, A.N. Faris, A.T. Comstock, Q. Wang, S. Nanua, and M.B. Hershenson et al. Quercetin inhibits rhinovirus replication in vitro and in vivo Antiviral Res 94 2012 258 271
36. M. Eropkin, T. Gudkova, N. Konovalova, S. Shchekanova, I. Iaglovskaia, and E. Eropkina et al. Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A (H3N2) virus studied in in vitro models Eksp Klin Farmakol 70 2007 33 37
37. H.J. Choi, J.H. Song, K.S. Park, and D.H. Kwon Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication Eur J Pharm Sci 37 2009 329 333
38. H.J. Choi, J.H. Song, and D.H. Kwon Quercetin 3â€rhamnoside exerts antiinfluenza A virus activity in mice Phytother Res 26 2012 462 464
39. C. Chen, Z.-Y. Jiang, B. Yu, X.-L. Wu, C.-Q. Dai, and C.-L. Zhao et al. Study on the anti-H1N1 virus effects of quercetin and oseltamivir and their mechanism related to TLR7 pathway J Asian Nat Prod Res 14 2012 877 885
40. E. Haslam Natural polyphenols (vegetable tannins) as drugs: possible modes of action J Nat Prod 59 1996 205 215
41. J. Li, H. Huang, W. Zhou, M. Feng, and P. Zhou Anti-hepatitis B virus activities of Geranium carolinianum L. extracts and identification of the active components Biol Pharm Bull 31 2008 743 747
42. S.-Y. Lyu, J.-Y. Rhim, and W.-B. Park Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro Arch Pharmacal Res 28 2005 1293 1301
43. T. Zhang, Z. Wu, J. Du, Y. Hu, L. Liu, and F. Yang et al. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics PLoS ONE 7 2012 e30259
44. H.J. Jeong, Y.B. Ryu, S.-J. Park, J.H. Kim, H.-J. Kwon, and J.H. Kim et al. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities Bioorg Med Chem 17 2009 6816 6823
45. Y. Liu, Z. Ke, K.Y. Wu, S. Liu, W.H. Chen, and S. Jiang et al. An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIVâ€1 gp41 fusion core formation ChemMedChem 6 2011 1654 1664
46. A.-L. Liu, H.-D. Wang, S.M. Lee, Y.-T. Wang, and G.-H. Du Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities Bioorg Med Chem 16 2008 7141 7147
47. J. Liu, Z. Yang, S. Wang, L. Liu, G. Chen, and L. Wang Exploring the molecular basis of H5N1 hemagglutinin binding with catechins in green tea: a flexible docking and molecular dynamics study J Theor Comput Chem 11 2012 111 125
48. S. Bustamante, and M. Morales Té verde, Fitomedicamento contra la Influenza A: Rol de las Catequinas Bol Latinoam Caribe Plant Med Arom 11 2012